139 related articles for article (PubMed ID: 9140718)
1. Clinical and hematological response to hydroxyurea in a patient with Hb Lepore/beta-thalassemia.
Rigano P; Manfré L; La Galla R; Renda D; Renda MC; Calabrese A; Calzolari R; Maggio A
Hemoglobin; 1997 May; 21(3):219-26. PubMed ID: 9140718
[TBL] [Abstract][Full Text] [Related]
2. Association of Hb S/Hb lepore and delta beta-thalassemia/Hb lepore in Sicilian patients: review of the presence of Hb lepore in Sicily.
Mirabile E; Testa R; Consalvo C; Dickerhoff R; Schilirò G
Eur J Haematol; 1995 Aug; 55(2):126-30. PubMed ID: 7543057
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture.
Watanapokasin R; Sanmund D; Winichagoon P; Muta K; Fucharoen S
Ann Hematol; 2006 Mar; 85(3):164-9. PubMed ID: 16389564
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.
Fucharoen S; Siritanaratkul N; Winichagoon P; Chowthaworn J; Siriboon W; Muangsup W; Chaicharoen S; Poolsup N; Chindavijak B; Pootrakul P; Piankijagum A; Schechter AN; Rodgers GP
Blood; 1996 Feb; 87(3):887-92. PubMed ID: 8562958
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients.
Watanapokasin Y; Chuncharunee S; Sanmund D; Kongnium W; Winichagoon P; Rodgers GP; Fucharoen S
Exp Hematol; 2005 Dec; 33(12):1486-92. PubMed ID: 16338491
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of hydroxyurea effects on fetal hemoglobin production in cultures of beta-thalassemia erythroid precursors.
Amoyal I; Goldfarb A; Fibach E
Hemoglobin; 2003 May; 27(2):77-87. PubMed ID: 12779269
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia.
Hoppe C; Vichinsky E; Lewis B; Foote D; Styles L
Am J Hematol; 1999 Dec; 62(4):221-7. PubMed ID: 10589077
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
[TBL] [Abstract][Full Text] [Related]
9. Role of XmnIgG Polymorphism in Hydroxyurea Treatment and Fetal Hemoglobin Level at Isfahanian Intermediate β-Thalassemia Patients.
Motovali-Bashi M; Ghasemi T
Iran Biomed J; 2015; 19(3):177-82. PubMed ID: 26024726
[TBL] [Abstract][Full Text] [Related]
10. A review of cis-trans interplay between DNA sequences 5' to the (G)gamma- and beta-globin genes among Hb F-Malta-I heterozygotes/homozygotes and beta-thalassemia homozygotes/compound heterozygotes, and the effects of hydroxyurea on the Hb F/F-erythrocyte; the need for large multicenter trials.
Felice AE; Borg J; Pizzuto M; Cassar W; Galdies R; Wettinger SB; Pulis S; Hunter GJ; Caruana MR; Farrugia M; Scerri CA
Hemoglobin; 2007; 31(2):279-88. PubMed ID: 17486512
[TBL] [Abstract][Full Text] [Related]
11. Induction of gamma-globin gene transcription by hydroxycarbamide in primary erythroid cell cultures from Lepore patients.
Calzolari R; Pecoraro A; Borruso V; Troia A; Acuto S; Maggio A; Di Marzo R
Br J Haematol; 2008 May; 141(5):720-7. PubMed ID: 18422777
[TBL] [Abstract][Full Text] [Related]
12. Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in beta thalassaemia.
Saxon BR; Rees D; Olivieri NF
Br J Haematol; 1998 Jun; 101(3):416-9. PubMed ID: 9633880
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin switching protocols in thalassemia. Experience with sodium phenylbutyrate and hydroxyurea.
Dover GJ
Ann N Y Acad Sci; 1998 Jun; 850():80-6. PubMed ID: 9668530
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea therapy in beta-thalassaemia intermedia: improvement in haematological parameters due to enhanced beta-globin synthesis.
Zeng YT; Huang SZ; Ren ZR; Lu ZH; Zeng FY; Schechter AN; Rodgers GP
Br J Haematol; 1995 Jul; 90(3):557-63. PubMed ID: 7646994
[TBL] [Abstract][Full Text] [Related]
15. Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India.
Jain M; Chakrabarti P; Dolai TK; Ghosh P; Mandal PK; Baul SN; De R
Blood Cells Mol Dis; 2021 May; 88():102544. PubMed ID: 33610115
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic treatment of thalassemia intermedia with hydroxyurea.
Hajjar FM; Pearson HA
J Pediatr; 1994 Sep; 125(3):490-2. PubMed ID: 7520935
[TBL] [Abstract][Full Text] [Related]
17. Long-term hydroxyurea therapy in beta-thalassaemia patients.
de Paula EV; Lima CS; Arruda VR; Alberto FL; Saad ST; Costa FF
Eur J Haematol; 2003 Mar; 70(3):151-5. PubMed ID: 12605659
[TBL] [Abstract][Full Text] [Related]
18. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.
Atweh GF; Sutton M; Nassif I; Boosalis V; Dover GJ; Wallenstein S; Wright E; McMahon L; Stamatoyannopoulos G; Faller DV; Perrine SP
Blood; 1999 Mar; 93(6):1790-7. PubMed ID: 10068649
[TBL] [Abstract][Full Text] [Related]
19. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.
Singer ST; Kuypers FA; Olivieri NF; Weatherall DJ; Mignacca R; Coates TD; Davies S; Sweeters N; Vichinsky EP
Ann N Y Acad Sci; 2005; 1054():250-6. PubMed ID: 16339672
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature.
Ehsani MA; Hedayati-Asl AA; Bagheri A; Zeinali S; Rashidi A
Pediatr Hematol Oncol; 2009 Nov; 26(8):560-5. PubMed ID: 19954365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
